RecruitingNCT06218901

Association of Psychological Distress in Patients With Lung Cancer

the Association of Psychological Distress in Patients With Advanced Lung Cancer Treated With Immunotherapy or Targeted Therapy


Sponsor

Shanghai Chest Hospital

Enrollment

500 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Psychological distress is a multi-factorial experience of a psychological, social, spiritual, and/or physical nature that may interfere with one's ability to cope effectively with cancer, physical symptoms and treatment. Psychological distress is common and affects the efficacy and prognosis of patients with lung cancer. The systematic anti-tumor therapy may effectively relieve psychological distress including anxiety, depression, and fatigue in patients with advanced lung cancer, the relief of the psychological distress can in turn improve the therapeutic effect. In summary, this study is to explore the associations of (dynamic) psychological stress with the efficacy and survival of anti-tumor therapy including immunotherapy and targeted therapy for advanced lung cancer patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Histologically proven diagnosis of lung cancer
  • years of age or older
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria1

  • Not willing to participate in this clinical trial

Interventions

DRUGimmunotherapy
DRUGTargeted Therapy Agent

Locations(1)

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06218901


Related Trials